Sigma Healthcare : Change of Director's Interest Notice

Appendix 3Y Change of Director's Interest Notice

Appendix 3Y

Rule 3.19A.2

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	SIGMA HEALTHCARE LIMITED
ABN	ABN 15 088 417 403
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director	Raymond Mark GUNSTON
Date of last notice	07/10/2020

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest
(including r g stered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change	16/12/2020
No. of securities held prior to change	541,102
Class	Direct - 541,102
	FPO
Number acquired	15,086
Number disposed
Value/Considerat on	$9,073.38
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change	556,188
	Direct - 556,188

+ See chapter 19 for defined terms.	Appendix 3Y Page 1
01/01/2011

Appendix 3Y

Change of Director's Interest Notice

	Example:Natureonof-marketchangetrade,off-market trade, exercise of options, issue		Shares purchased under NED's Share Plan
	of securities under dividend reinvestment plan, participation in buy-
	back

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract

Nature of interest

Name of registered holder (if issued securities)

Date of change

No. and class of securities to which

Note:interestDetailsrelatedare only priorrequiredtoforchangea contract in relation to which the interest has changed

Interest acquired

Interest disposed

Note:Value/ConsiderationIf consideration is non-cash, provide details and an estimated valuation

Interest after change

Part 3 - +Closed period

Were the interests in the securities or contracts detailed No above traded during a +closed period where prior written clearance was required?

If so, was prior written clearance provided to allow the trade to proceed during this period?

If prior written clearance was provided, on what date was this provided?

+ See chapter 19 for defined terms.	01/01/2011
Appendix 3Y Page 2

Appendix 3Y Change of Director's Interest Notice

Appendix 3Y

Rule 3.19A.2

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	SIGMA HEALTHCARE LIMITED
ABN	ABN 15 088 417 403
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director	Christine BARTLETT
Date of last notice	07/10/2020

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest
(including r g stered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change	16/12/2020
No. of securities held prior to change	129,583
Class	Direct - 129,583
	FPO
Number acquired	12,132
Number disposed
Value/Considerat on	$7,296.72
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change	141,715
	Direct - 141,715

+ See chapter 19 for defined terms.	Appendix 3Y Page 1
01/01/2011

Appendix 3Y

Change of Director's Interest Notice

Example:Natureonof-marketchangetrade,off-market trade, exercise of options, issue Shares purchased under NED's Share Plan of securities under dividend reinvestment plan, participation in buy-

back

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract

Nature of interest

Name of registered holder (if issued securities)

Date of change

No. and class of securities to which

Note:interestDetailsrelatedare only priorrequiredtoforchangea contract in relation to which the interest has changed

Interest acquired

Interest disposed

Note:Value/ConsiderationIf consideration is non-cash, provide details and an estimated valuation

Interest after change

Part 3 - +Closed period

Were the interests in the securities or contracts detailed No above traded during a +closed period where prior written clearance was required?

If so, was prior written clearance provided to allow the trade to proceed during this period?

If prior written clearance was provided, on what date was this provided?

+ See chapter 19 for defined terms.	01/01/2011
Appendix 3Y Page 2